A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hope Rugo Denise A Yardley Ian E Krop Kathy D. Miller Eric Winer Shanu Modi |
| Publication date | May 29, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |